Genomic-Wide Analysis with Microarrays in Human Oncology
- PMID: 27600234
- PMCID: PMC4996403
- DOI: 10.3390/microarrays4040454
Genomic-Wide Analysis with Microarrays in Human Oncology
Abstract
DNA microarray technologies have advanced rapidly and had a profound impact on examining gene expression on a genomic scale in research. This review discusses the history and development of microarray and DNA chip devices, and specific microarrays are described along with their methods and applications. In particular, microarrays have detected many novel cancer-related genes by comparing cancer tissues and non-cancerous tissues in oncological research. Recently, new methods have been in development, such as the double-combination array and triple-combination array, which allow more effective analysis of gene expression and epigenetic changes. Analysis of gene expression alterations in precancerous regions compared with normal regions and array analysis in drug-resistance cancer tissues are also successfully performed. Compared with next-generation sequencing, a similar method of genome analysis, several important differences distinguish these techniques and their applications. Development of novel microarray technologies is expected to contribute to further cancer research.
Keywords: combination array; gene expression; microarray.
Similar articles
-
Advantages of next-generation sequencing versus the microarray in epigenetic research.Brief Funct Genomic Proteomic. 2009 May;8(3):174-83. doi: 10.1093/bfgp/elp013. Epub 2009 Jun 17. Brief Funct Genomic Proteomic. 2009. PMID: 19535508 Review.
-
Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.BMC Genomics. 2006 Mar 21;7:59. doi: 10.1186/1471-2164-7-59. BMC Genomics. 2006. PMID: 16551369 Free PMC article.
-
Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.Scand J Clin Lab Invest Suppl. 2016;245:S84-91. doi: 10.1080/00365513.2016.1210331. Epub 2016 Aug 17. Scand J Clin Lab Invest Suppl. 2016. PMID: 27542004
-
Applications of nanotechnology, next generation sequencing and microarrays in biomedical research.J Nanosci Nanotechnol. 2013 Jul;13(7):4539-51. doi: 10.1166/jnn.2013.7522. J Nanosci Nanotechnol. 2013. PMID: 23901472 Review.
-
Apply innovative technologies to explore cancer genome.Curr Opin Oncol. 2005 Jan;17(1):33-8. doi: 10.1097/01.cco.0000147382.97085.e4. Curr Opin Oncol. 2005. PMID: 15608510 Review.
Cited by
-
Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.Aging (Albany NY). 2019 Jun 6;11(11):3601-3623. doi: 10.18632/aging.102000. Aging (Albany NY). 2019. PMID: 31170090 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources